Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-12-06 Purchase |
2021-12-07 4:13 pm |
Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer |
4,000 | $24.4 | $97,600 | 4,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-11 Option Award |
2024-03-12 6:42 pm |
N/A 2034-03-10 |
Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2023-03-10 Option Award |
2023-03-14 4:47 pm |
N/A 2033-03-09 |
Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer |
90,000 | $0 | 90,000 (Direct) |
View |
| 2022-03-10 Option Award |
2022-03-14 4:24 pm |
N/A 2032-03-09 |
Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
| 2021-03-12 Option Award |
2021-03-15 4:45 pm |
N/A 2031-03-11 |
Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer |
60,000 | $0 | 60,000 (Direct) |
View |
| 2020-08-17 Option Award |
2020-08-17 6:38 pm |
N/A 2030-08-16 |
Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer |
100,000 | $0 | 100,000 (Direct) |
View |
Ownership |
2020-08-17 4:54 pm |
N/A N/A |
Xenon Pharmaceuticals Inc. | XENE | Von Seggern Christopher Chief Commercial Officer |
0 | $0 | 0 (Direct) |
View |